Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Kazuma Sugimoto"'
Autor:
Yuta Yamada, Yoichi Fujii, Shigenori Kakutani, Naoki Kimura, Kazuma Sugimoto, Yuji Hakozaki, Toru Sugihara, Yuta Takeshima, Taketo Kawai, Masaki Nakamura, Jun Kamei, Satoru Taguchi, Yoshiyuki Akiyama, Yusuke Sato, Daisuke Yamada, Fumihiko Urabe, Hideyo Miyazaki, Yutaka Enomoto, Hiroshi Fukuhara, Tohru Nakagawa, Tetsuya Fujimura, Haruki Kume
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract A total of 739 patients underwent RARP as initial treatment for PCa from November 2011 to October 2018. Data on BCR status, clinical and pathological parameters were collected from the clinical records. After excluding cases with neoadjuvant
Externí odkaz:
https://doaj.org/article/4034a869272247099ed451b005d04ac3
Autor:
Kazuma Sugimoto, Satoru Taguchi, Kenjiro Kishitani, Taketo Kawai, Kazuki Masuda, Yu Nakamura, Manami Kinjo, Mitsuhiro Tambo, Jimpei Miyakawa, Yoshiyuki Akiyama, Yuta Yamada, Yusuke Sato, Daisuke Yamada, Tohru Nakagawa, Hiroshi Fukuhara, Haruki Kume
Publikováno v:
BMC Urology, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background While gemcitabine/cisplatin (GC) is the gold standard regimen for patients with advanced urothelial carcinoma (aUC), either dose-reduced GC or gemcitabine/carboplatin (GCa) is an alternative option for “cisplatin-unfit” patien
Externí odkaz:
https://doaj.org/article/18e17e7885da4a46b1c137ccd711619c
Autor:
Satoru Taguchi, Taketo Kawai, Sebastiano Buti, Melissa Bersanelli, Yukari Uemura, Kenjiro Kishitani, Jimpei Miyakawa, Kazuma Sugimoto, Yu Nakamura, Fusako Niimi, Tomoyuki Kaneko, Jun Kamei, Daisuke Obinata, Kenya Yamaguchi, Shigenori Kakutani, Koichiro Kanazawa, Yuriko Sugihara, Mayuko Tokunaga, Yoshiyuki Akiyama, Yuta Yamada, Yusuke Sato, Daisuke Yamada, Yutaka Enomoto, Hiroaki Nishimatsu, Tetsuya Fujimura, Hiroshi Fukuhara, Tohru Nakagawa, Satoru Takahashi, Haruki Kume
Publikováno v:
Immunotherapy.
Aim: To validate a ‘drug score’ that stratifies patients receiving immunotherapy based on concomitant medications (antibiotics/proton pump inhibitors/corticosteroids) in urothelial carcinoma (UC). Materials & methods: We assessed oncological outc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3df135d5f009a597ad7ddc8f7b9116bf
https://doi.org/10.2217/imt-2023-0028
https://doi.org/10.2217/imt-2023-0028
Autor:
Toyohiro Hashiba, Mai Sugahara, Yui Ota, Ken Kaseda, Yusuke Kashiwagi, Motonobu Nakamura, Takayuki Shinohara, Mahoko Ikeda, Shu Okugawa, Kazuma Sugimoto, Kenichi Sasaki, Yoshifumi Hamasaki, Daisuke Yamada, Haruki Kume, Kyoji Moriya, Masaomi Nangaku
Publikováno v:
Internal Medicine; 2023, Vol. 62 Issue 17, p2559-2564, 6p
Autor:
Takahiro Tabuchi, Masashi Nakayama, Toshitaka Morishima, Kazuo Nishimura, Kazuma Sugimoto, Shihoko Koyama, Isao Miyashiro, Sumiyo Okawa
Publikováno v:
International Journal of Urology. 28:799-805
Objective To examine the association between hospital volume and postoperative 5-year survival for patients with prostate, kidney, and bladder cancer. Method Using Osaka Cancer Registry data, we identified 9285 patients who were diagnosed as having p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9ffd17d2c06d164ffbcc04ed97a41c9
https://doi.org/10.1111/iju.14573
https://doi.org/10.1111/iju.14573
Publikováno v:
International Journal of General Medicine
Background Acyclovir (ACV) neurotoxicity is a neuropsychiatric condition induced by the anti-herpetic drugs ACV and valacyclovir (VACV). It is presumed that elevated blood levels of ACV and its metabolite 9-carboxymethoxymethylguanine are involved in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5f1c0cb417e31a29b86d13f27b5e26de
http://www.lib.kobe-u.ac.jp/handle_kernel/90007955
http://www.lib.kobe-u.ac.jp/handle_kernel/90007955
Autor:
Satoru Taguchi, Taketo Kawai, Tohru Nakagawa, Jimpei Miyakawa, Kenjiro Kishitani, Kazuma Sugimoto, Yu Nakamura, Jun Kamei, Daisuke Obinata, Kenya Yamaguchi, Tomoyuki Kaneko, Kanae Yoshida, Sachi Yamamoto, Shigenori Kakutani, Koichiro Kanazawa, Yuriko Sugihara, Mayuko Tokunaga, Akihiko Matsumoto, Yukari Uemura, Yoshiyuki Akiyama, Yuta Yamada, Yusuke Sato, Daisuke Yamada, Yutaka Enomoto, Hiroaki Nishimatsu, Akira Ishikawa, Yoshinori Tanaka, Yasushi Nagase, Tetsuya Fujimura, Hiroshi Fukuhara, Satoru Takahashi, Haruki Kume
Publikováno v:
International journal of urology : official journal of the Japanese Urological AssociationREFERENCES.
Although the treatment strategy for advanced urothelial carcinoma (aUC) has drastically changed since pembrolizumab was introduced in 2017, studies revealing current survival rates in aUC are lacking. This study aimed to assess (1) the improvement in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7195ac108390a5bfbb4b4dbadf100b2b
https://pubmed.ncbi.nlm.nih.gov/35996761
https://pubmed.ncbi.nlm.nih.gov/35996761
Publikováno v:
The Journal of organic chemistry. 86(18)
Treatment of aryl-fused bicyclo[4.2.0]octanols with an oxidant such as phenyliodine diacetate (PIDA) or hypochlorous acid gave dihydrofuran-containing polycyclic aromatic compounds by selective β-cleavage of the cyclobutanol moiety. Mechanistic stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d7f9cf353ed327e63e75a30ee722b680
https://pubmed.ncbi.nlm.nih.gov/34474562
https://pubmed.ncbi.nlm.nih.gov/34474562
Autor:
Young Ji Park, Sun Woog Kim, Koudai Tanima, Takuya Hasegawa, Kenji Toda, Kazuyoshi Uematsu, Mineo Satod, Kazuma Sugimoto
Publikováno v:
Journal of Ceramic Processing Research. 20:460-463
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b4e651edcef056ab25d4876cdde99802
https://doi.org/10.36410/jcpr.2019.20.5.460
https://doi.org/10.36410/jcpr.2019.20.5.460
Publikováno v:
Journal of Ceramic Processing Research. 20:205-210
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5d28554613a55cd47017a05e9958567d
https://doi.org/10.36410/jcpr.2019.20.3.205
https://doi.org/10.36410/jcpr.2019.20.3.205